ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group., 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363 :9–17.
-
2
Kremsner PG, Krishna S, 2004. Antimalarial combinations. Lancet 364 :285–294.
-
3
Ashley EA, White NJ, 2005. Artemisinin-based combinations. Curr Opin Infect Dis 18 :531–536.
-
4
Leonardi E, Gilvary G, White NJ, Nosten F, 2001. Severe allergic reactions to oral artesunate: a report of two cases. Trans R Soc Trop Med Hyg 95 :182–183.
-
5
Genovese RF, Nguyen HA, Mog SR, 2001. Effects of arteether on an auditory radial-arm maze task in rats. Physiol Behav 73 :87–91.
-
6
Genovese RF, Newman DB, Brewer TG, 2000. Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats. Pharmacol Biochem Behav 67 :37–44.
-
7
Panossian LA, Garga NI, Pelletier D, 2005. Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann Neurol 58 :812–813.
-
8
Toovey S, Jamieson A, 2004. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98 :261–267.
-
9
Haynes RK, Fugmann B, Stetter J, Rieckmann K, Heilmann HD, Chan HW, Cheung MK, Lam WL, Wong HN, Croft SL, Vivas L, Rattray L, Steward L, Peters W, Robinson BL, Edstein MD, Kotecka B, Kyle DE, Beckermann B, Gerisch M, Radtke M, Schmuck G, Steinke W, Wollborn U, Schmeer K, Römer A, 2006. Artemisone: a highly active antimalarial drug of the artemisinin class. Angew Chem Int Ed Engl 45 :2082–2088.
-
10
Borrmann S, Binder RK, Adegnika AA, Missinou MA, Issifou S, Ramharter M, Wernsdorfer WH, Kremsner PG, 2002. Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans R Soc Trop Med Hyg 96 :660–663.
-
11
Ramharter M, Wernsdorfer WH, Kremsner PG, 2004. In vitro activity of quinolines against Plasmodium falciparum in Gabon. Acta Trop 90 :55–60.
-
12
Uhlemann AC, Ramharter M, Lell B, Kremsner PG, Krishna S, 2005. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis 192 :1830–1835.
-
13
Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C, 2002. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother 46 :1658–1664.
-
14
Lietchfield JT, Wilcoxon F, 1949. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96 :99–113.
-
15
World Health Organization, 2001. The Use of Antimalarial Drugs. Report of an Informal Consultation. Geneva: World Health Organization. WHO/CDS/RBM/2001.33.
-
16
Facts on ACTs (ArtemisininBased Combination Therapies. Accessed February 1, 2006. Available from http://www.rbm.who.int/cmc_upload/0/000/015/364/RBMInfosheet_9.htm
-
17
Hutagalung R, Htoo H, Nwee P, Arunkamomkiri J, Zwang J, Carrara VI, Ashley E, Singhasivanon P, White N, Nosten F, 2006. A case-control auditory evaluation of patients treated with artemether-lumefantrine. Am J Trop Med Hyg 74 :211–214.
-
18
Eckstein-Ludwig U, Webb RJ, van Goethem ID, East JM, Lee AG, Kimura M, O’Neill PM, Bray PG, Ward SA, Krishna S, 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424 :957–961.
-
19
Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, 2005. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol 12 :628–629.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 302 | 283 | 86 |
| Full Text Views | 310 | 4 | 1 |
| PDF Downloads | 39 | 4 | 1 |
IN VITRO ACTIVITY OF ARTEMISONE COMPARED WITH ARTESUNATE AGAINST PLASMODIUM FALCIPARUM
MICHAEL RAMHARTER
MICHAEL RAMHARTER
Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Austria; Department of Parasitology, Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany
Search for other papers by MICHAEL RAMHARTER in
Current site
Google Scholar
PubMed
Search for other papers by MICHAEL RAMHARTER in
Current site
Google Scholar
PubMed
DOMINIK BURKHARDT
DOMINIK BURKHARDT
Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Austria; Department of Parasitology, Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany
Search for other papers by DOMINIK BURKHARDT in
Current site
Google Scholar
PubMed
Search for other papers by DOMINIK BURKHARDT in
Current site
Google Scholar
PubMed
JOHANNES NEMETH
JOHANNES NEMETH
Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Austria; Department of Parasitology, Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany
Search for other papers by JOHANNES NEMETH in
Current site
Google Scholar
PubMed
Search for other papers by JOHANNES NEMETH in
Current site
Google Scholar
PubMed
AYOLA A. ADEGNIKA
AYOLA A. ADEGNIKA
Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Austria; Department of Parasitology, Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany
Search for other papers by AYOLA A. ADEGNIKA in
Current site
Google Scholar
PubMed
Search for other papers by AYOLA A. ADEGNIKA in
Current site
Google Scholar
PubMed
PETER G. KREMSNER
PETER G. KREMSNER
Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Austria; Department of Parasitology, Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany
Search for other papers by PETER G. KREMSNER in
Current site
Google Scholar
PubMed
Search for other papers by PETER G. KREMSNER in
Current site
Google Scholar
PubMed
Artemisinins show the potential for neurotoxicity in preclinical studies. Artemisone is a leading candidate of second-generation semi-synthetic artemisinin derivatives for antimalarial therapy devoid of neurotoxicity. Artemisone showed 3–5-fold higher in vitro activity (50% effective concentration (EC50) = 0.14 nmol/L, EC90 = 2.55 nmol/L) than artesunate against fresh Plasmodium falciparum isolates from Gabon and a high-activity correlation indicates a shared drug target.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group., 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363 :9–17.
-
2
Kremsner PG, Krishna S, 2004. Antimalarial combinations. Lancet 364 :285–294.
-
3
Ashley EA, White NJ, 2005. Artemisinin-based combinations. Curr Opin Infect Dis 18 :531–536.
-
4
Leonardi E, Gilvary G, White NJ, Nosten F, 2001. Severe allergic reactions to oral artesunate: a report of two cases. Trans R Soc Trop Med Hyg 95 :182–183.
-
5
Genovese RF, Nguyen HA, Mog SR, 2001. Effects of arteether on an auditory radial-arm maze task in rats. Physiol Behav 73 :87–91.
-
6
Genovese RF, Newman DB, Brewer TG, 2000. Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats. Pharmacol Biochem Behav 67 :37–44.
-
7
Panossian LA, Garga NI, Pelletier D, 2005. Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann Neurol 58 :812–813.
-
8
Toovey S, Jamieson A, 2004. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98 :261–267.
-
9
Haynes RK, Fugmann B, Stetter J, Rieckmann K, Heilmann HD, Chan HW, Cheung MK, Lam WL, Wong HN, Croft SL, Vivas L, Rattray L, Steward L, Peters W, Robinson BL, Edstein MD, Kotecka B, Kyle DE, Beckermann B, Gerisch M, Radtke M, Schmuck G, Steinke W, Wollborn U, Schmeer K, Römer A, 2006. Artemisone: a highly active antimalarial drug of the artemisinin class. Angew Chem Int Ed Engl 45 :2082–2088.
-
10
Borrmann S, Binder RK, Adegnika AA, Missinou MA, Issifou S, Ramharter M, Wernsdorfer WH, Kremsner PG, 2002. Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans R Soc Trop Med Hyg 96 :660–663.
-
11
Ramharter M, Wernsdorfer WH, Kremsner PG, 2004. In vitro activity of quinolines against Plasmodium falciparum in Gabon. Acta Trop 90 :55–60.
-
12
Uhlemann AC, Ramharter M, Lell B, Kremsner PG, Krishna S, 2005. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis 192 :1830–1835.
-
13
Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C, 2002. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother 46 :1658–1664.
-
14
Lietchfield JT, Wilcoxon F, 1949. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96 :99–113.
-
15
World Health Organization, 2001. The Use of Antimalarial Drugs. Report of an Informal Consultation. Geneva: World Health Organization. WHO/CDS/RBM/2001.33.
-
16
Facts on ACTs (ArtemisininBased Combination Therapies. Accessed February 1, 2006. Available from http://www.rbm.who.int/cmc_upload/0/000/015/364/RBMInfosheet_9.htm
-
17
Hutagalung R, Htoo H, Nwee P, Arunkamomkiri J, Zwang J, Carrara VI, Ashley E, Singhasivanon P, White N, Nosten F, 2006. A case-control auditory evaluation of patients treated with artemether-lumefantrine. Am J Trop Med Hyg 74 :211–214.
-
18
Eckstein-Ludwig U, Webb RJ, van Goethem ID, East JM, Lee AG, Kimura M, O’Neill PM, Bray PG, Ward SA, Krishna S, 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424 :957–961.
-
19
Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, 2005. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol 12 :628–629.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 302 | 283 | 86 |
| Full Text Views | 310 | 4 | 1 |
| PDF Downloads | 39 | 4 | 1 |